ESC Premium Access

Poster Session 5 - Acute coronary syndrome treatment

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 2 September 2019

Congress Session

13 presentations in this session

Strict versus no fasting prior to cardiac catheterization: a prospective evaluation of safety and clinical outcomes

Speaker: Doctor A. Mishra (Sayre, PA, US)

Intraventricular conduction disturbance and ventricular paced rhythms in patients with acute coronary syndromes

Speaker: Doctor P. Azevedo (Faro, PT)

Reduced exercise capacity and clinical outcomes following acute myocardial infarction

Speaker: Doctor H. Tashiro (Nagoya, JP)

Ultrasound targeted delivery of exosomes derived from bone mesenchymal stem cells stimulate angiogenesis and reduce adverse remodeling after myocardial infarction

Speaker: Doctor Q. Deng (Wuhan, CN)

Exercise training after acute coronary syndromes in the octogenarians has beneficial effect on the course of the disease and the exercise tolerance - single-center, prospective 12-months evaluation.

Speaker: Professor R. Dabrowski (Warsaw, PL)

Insights into left ventricular remodelling and clinical outcomes after Wharton's jelly multipotent stem cells transcoronary administration in a pilot cohort of CIRCULATE-AMI Trial (NCT03404063)

Speaker: Doctor E. Kwiecien (Krakow, PL)

Landiolol, a beta-blocker, optimizes cardiac energetics and peripheral microhemodynamics better than ivabradine while reducing heart rate at hemodynamic resuscitation of experimental septic shock

Speaker: Doctor K. UEMURA (Suita, JP)

Comparing biomarker profiles in patients with stable atherosclerosis treated with anacetrapib versus placebo: a nested proteomic study from HPS3/TIMI 55-REVEAL

Speaker: Doctor D. Berg (Boston, US)

A specific complex I-induced ROS modulator, OP2113, is a new cardioproctective agent against acute myocardial infarction injuries during reperfusion.

Speaker: Doctor A. Boucard (Bordeaux, FR)

BET-inhibition with Apabetalone in Post-ACS Patients with Diabetes: Design and Baseline Characteristics of the BETonMACE trial

Speaker: Professor K. Ray (London, GB)

13 speakers from this session

Doctor Abhishek Mishra

Guthrie Clinic, Sayre, PA (United States of America)
0 follower

Doctor Pedro Azevedo

Faro Hospital, Faro (Portugal)
0 follower

Doctor Hiroshi Tashiro

Nagoya University Hospital, Nagoya (Japan)
0 follower

Doctor Qing Deng

Renmin Hospital of Wuhan University, Wuhan (China)
0 follower

Professor Rafal Dabrowski

National Institute of Cardiology, Warsaw (Poland)
0 follower

Doctor Ewa Kwiecien

John Paul II Hospital, Krakow (Poland)
0 follower

Doctor Kazunori UEMURA

National Cerebral & Cardiovascular Center, Suita (Japan)
0 follower

Doctor David Berg

Brigham and Women's Hospital, Boston (United States of America)
2 presentations
0 follower

Doctor Aurelie Boucard

OP2 Drugs, Bordeaux (France)
0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
1 follower

Doctor Otakar Jiravsky

Hospital Podlesi, Trinec (Czechia)
0 follower

Professor Karlheinz Peter

Baker Heart and Diabetes Institute, Melbourne (Australia)
4 presentations
0 follower

Associate Professor Azita Haj Hossein Talasaz

Tehran University of Medical Sciences, Tehran (Iran (Islamic Republic of))
0 follower

This platform is supported by

logo Novo Nordisk